Feature Channels:

Clinical Trials

Add to Favorites Subscribe Share
fbshare-Clinical Trials

Showing results

110 of 170
RushMed_logo.png

Participants Sought for National Trial to Test Benefits of a Healthy Lifestyle

Rush University Medical Center

The Enhanced Lifestyles for Metabolic Syndrome (ELM) Trial, a multisite test of two lifestyle treatments for a dangerous cluster of sub-disease indicators called the metabolic syndrome, is now accepting applicants at five medical centers around the country.

Channels: All Journal News, Cancer, Clinical Trials, Diabetes, Exercise and Fitness, Heart Disease, Nutrition,

Released:
15-Nov-2019 1:10 PM EST
Newswise: Findings could help identify aggressive breast cancers that will respond to immunotherapy

Findings could help identify aggressive breast cancers that will respond to immunotherapy

University of North Carolina Health Care System

University of North Carolina Lineberger Comprehensive Cancer Center researchers have discovered a promising method to identify aggressive breast cancer tumors that will respond to drugs that unleash the immune system against cancer.

Channels: All Journal News, Cancer, Clinical Trials, Immunology, Pharmaceuticals, Women's Health,

Released:
14-Nov-2019 11:05 AM EST
Announcement
Embargo will expire:
20-Nov-2019 12:00 AM EST
Released to reporters:
14-Nov-2019 11:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 20-Nov-2019 12:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Limited Availability of Lupus Laboratory Tests, Such As ANA, in Developing Nations Affects Global Usefulness of Criteria and Clinical Trials

American College of Rheumatology (ACR)

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, supportive laboratory assays to diagnose lupus, specifically the antinuclear antibody (ANA) test, are less often offered in developing nations due to a relative lack of resources.

Channels: Autoimmune Diseases, Clinical Trials, Lupus, Medical Meetings,

Released:
6-Nov-2019 12:00 PM EST
Research Results
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Methotrexate Significantly Reduces Joint Damage Progression Over Placebo in Erosive Hand OA, and May Facilitate Bone Remodeling

American College of Rheumatology (ACR)

According to new research findings presented at the 2019 ACR/ARP Annual Meeting, methotrexate did not demonstrate superior efficacy over placebo for pain relief and function evolution at three and 12 months in patients with erosive hand osteoarthritis, but did significantly reduce the progression of joint damage over placebo and seems to facilitate bone remodeling in these patients

Channels: Aging, All Journal News, Arthritis, Bone Health, Clinical Trials, Pharmaceuticals, Seniors, Medical Meetings, Autoimmune Diseases,

Released:
6-Nov-2019 12:00 PM EST
Research Results
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

American College of Rheumatology Previews Draft of Updated Gout Treatment Guideline at the 2019 ACR/ARP Annual Meeting

American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) is previewing draft recommendations from an updated treatment guideline for managing patients with gout during the 2019 ACR/ARP Annual Meeting in Atlanta.

Channels: All Journal News, Clinical Trials, Healthcare, Medical Meetings, Autoimmune Diseases,

Released:
6-Nov-2019 12:00 PM EST
Research Results
AACC_HEX_Stacked.gif

Breaking Research in AACC’s Clinical Chemistry Journal Debunks the Claim That Vitamin D and Fish Oil Supplements Reduce Inflammation

American Association for Clinical Chemistry (AACC)

One of the many advertised benefits of vitamin D and fish oil supplements is that they reduce systemic inflammation, which in turn could help prevent certain chronic illnesses. However, a first-of-its-kind study published in AACC’s journal Clinical Chemistry has discovered that these two supplements do not actually reduce inflammation in healthy individuals, a finding that could help consumers make more informed choices about which supplements they decide to take.

Channels: All Journal News, Chemistry, Clinical Trials, Healthcare, Pharmaceuticals, 71st AACC Annual Scientific Meeting & Clinical Lab Expo,

Released:
7-Nov-2019 4:20 PM EST
Feature

Sled dogs lead the way in quest to slow aging

Cornell University

As the winter months approach, nearly 100 Alaskan sled dogs between the ages of 8 and 13 – former athletes past their glory days – are participating in a $4.2 million study at Cornell University in a quest for one of the holy grails of medicine: how to slow aging.

Channels: Aging, All Journal News, Clinical Trials, Pets, Pharmaceuticals,

Released:
7-Nov-2019 1:55 PM EST
Research Results
Newswise: Quality of Life Changes After Weight Loss

Quality of Life Changes After Weight Loss

University of Pennsylvania School of Nursing

Obesity increases a number of adverse health consequences including reduced health-related quality of life. But little is known about the relationship between weight loss and changes in quality of life.

Channels: All Journal News, Clinical Trials, Healthcare, Obesity, Weight Loss, Medical Meetings,

Released:
5-Nov-2019 3:40 PM EST
Feature

Human Immune Monitoring Center at Mount Sinai to analyze the effectiveness of a novel cancer therapy drug

Mount Sinai Health System

The Human Immune Monitoring Center (HIMC) at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of Libtayo® (cemiplimab-rwlc), a PD-1 antibody blockade developed by biotechnology company Regeneron Pharmaceuticals, Inc and Sanofi.

Channels: Cancer, Clinical Trials, Immunology,

Released:
5-Nov-2019 9:00 AM EST
Research Results

Showing results

110 of 170

Chat now!
4.6913